Upstate Active Clinical Trials
Study Title:A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition
What is the purpose of the study?Treatment study to look at giving lestaurtinib together with combination chemotherapy to see how well it works compared to combination chemotherapy alone in treating infants with newly diagnosed acute lymphoblastic leukemia.
Upstate Institutional Review Board (IRB) Number:237445
Patient Age Group:Children
Principal Investigator:Karol H Kerr, MD
Who can I contact for more information?
Name: Beatriz Kovar